Detachment of ligands from nanoparticle surface under flow and endothelial cell contact: Assessment using microfluidic devices

Abstract Surface modification of nanoparticles is a well‐established methodology to alter their properties to enhance circulation half‐life. While literature studies using conventional, in vitro characterization are routinely used to evaluate the biocompatibility of such modifications, relatively little attention has been paid to assess the stability of such surface modifications in physiologically relevant conditions. Here, microfluidic devices were used to study the effect of factors that adversely impact surface modifications including vascular flow and endothelial cell interactions. Camptothecin nanoparticles coated with polyethylene glycol (PEG) and/or folic acid were analyzed using linear channels and microvascular networks. Detachment of PEG was observed in cell‐free conditions and was attributed to interplay between the flow and method of PEG attachment. The flow and cells also impacted the surface charge of nanoparticles. Presence of endothelial cells further increased PEG shedding. The results demonstrate that endothelial cell contact, and vascular flow parameters modify surface ligands on nanoparticle surfaces.

[1]  Yadong Yin,et al.  Colloidal nanocrystal synthesis and the organic–inorganic interface , 2005, Nature.

[2]  S. Mitragotri,et al.  Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[3]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[4]  M. Manimaran,et al.  Multi-step microfluidic device for studying cancer metastasis. , 2007, Lab on a chip.

[5]  H. Van Swygenhoven,et al.  Dimples on Nanocrystalline Fracture Surfaces As Evidence for Shear Plane Formation , 2003, Science.

[6]  Rachel W. Kasinskas,et al.  A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeutics. , 2009, Lab on a chip.

[7]  S. Vyas,et al.  Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. , 2001, Critical reviews in therapeutic drug carrier systems.

[8]  S. Mitragotri,et al.  Microfluidic co‐culture devices to assess penetration of nanoparticles into cancer cell mass , 2017, Bioengineering & translational medicine.

[9]  Si-Shen Feng,et al.  Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. , 2005, Biomaterials.

[10]  Kapil Pant,et al.  Synthetic tumor networks for screening drug delivery systems. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Sidney Yip,et al.  Nanocrystals: The strongest size , 1998, Nature.

[12]  M. Mayo,et al.  Structure and Mechanical Behavior of Bulk Nanocrystalline Materials , 1999 .

[13]  M. Laberge,et al.  Frictional Behavior of Individual Vascular Smooth Muscle Cells Assessed By Lateral Force Microscopy , 2010, Materials.

[14]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[15]  K. Pant,et al.  Generation of shear adhesion map using SynVivo synthetic microvascular networks. , 2014, Journal of visualized experiments : JoVE.

[16]  Kapil Pant,et al.  Microfluidic devices for modeling cell-cell and particle-cell interactions in the microvasculature. , 2011, Microvascular research.

[17]  J. Reddy,et al.  Folate-targeted chemotherapy. , 2004, Advanced drug delivery reviews.

[18]  A Alexander-Katz,et al.  Shear-induced unfolding triggers adhesion of von Willebrand factor fibers , 2007, Proceedings of the National Academy of Sciences.

[19]  R. Tiwari,et al.  Drug delivery systems: An updated review , 2012, International journal of pharmaceutical investigation.

[20]  Weihong Tan,et al.  Aptamer-enabled efficient isolation of cancer cells from whole blood using a microfluidic device. , 2012, Analytical chemistry.

[21]  S. Mitragotri,et al.  Synergistic targeting of cell membrane, cytoplasm, and nucleus of cancer cells using rod-shaped nanoparticles. , 2013, ACS nano.

[22]  Francesco Stellacci,et al.  Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.

[23]  T. Allen Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.

[24]  B. Ladoux,et al.  Dynamics of a tethered polymer in shear flow. , 2000, Physical review letters.

[25]  A. Mukherjee,et al.  Deformation of nanocrystalline materials by molecular-dynamics simulation: relationship to experiments? , 2005 .

[26]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[27]  Francesco M Veronese,et al.  PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.

[28]  R. Kamm,et al.  Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function , 2012, Proceedings of the National Academy of Sciences.

[29]  Leaf Huang,et al.  Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Robert Gurny,et al.  Current methods for attaching targeting ligands to liposomes and nanoparticles. , 2004, Journal of pharmaceutical sciences.

[31]  S. Zalipsky Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. , 1995, Bioconjugate chemistry.

[32]  Hazem Salim Damiri,et al.  Numerical design and optimization of hydraulic resistance and wall shear stress inside pressure-driven microfluidic networks. , 2015, Lab on a chip.

[33]  R. Langer,et al.  Designing materials for biology and medicine , 2004, Nature.

[34]  Shuming Nie,et al.  Emerging use of nanoparticles in diagnosis and treatment of breast cancer. , 2006, The Lancet. Oncology.

[35]  Rainer H Müller,et al.  Nanocrystal technology, drug delivery and clinical applications , 2008, International journal of nanomedicine.

[36]  P. Davies,et al.  Haemodynamic shear stress activates a K+ current in vascular endothelial cells , 1988, Nature.

[37]  Weihong Tan,et al.  Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. , 2009, Analytical chemistry.

[38]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[39]  Gwo-Bin Lee,et al.  Microfluidic cell culture systems for drug research. , 2010, Lab on a chip.

[40]  E. Frenkel,et al.  Nanoparticles for drug delivery in cancer treatment. , 2008, Urologic oncology.

[41]  S. Chien,et al.  Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. , 2011, Physiological reviews.

[42]  Norased Nasongkla,et al.  Functionalized Micellar Systems for Cancer Targeted Drug Delivery , 2007, Pharmaceutical Research.

[43]  S. Mitragotri,et al.  DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[44]  S. Lai,et al.  Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation. , 2014, Molecular pharmaceutics.